Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Conditions

Breast Neoplasms 2936 Neoplasms 2636 Lung Neoplasms 1374 Colorectal Neoplasms 1332 Prostatic Neoplasms 1216 Carcinoma, Non-Small-Cell Lung 1081 Carcinoma, Hepatocellular 785 Stomach Neoplasms 721 Pancreatic Neoplasms 704 Ovarian Neoplasms 586 Colonic Neoplasms 534 Uterine Cervical Neoplasms 497 Head and Neck Neoplasms 497 Rectal Neoplasms 472 Melanoma 467 Multiple Myeloma 464 Esophageal Neoplasms 423 Neoplasm Metastasis 418 Brain Neoplasms 408 Lymphoma 400 Precursor Cell Lymphoblastic Leukemia-Lymphoma 399 Urinary Bladder Neoplasms 387 Leukemia, Myeloid, Acute 387 Leukemia 339 Carcinoma, Renal Cell 329 Liver Neoplasms 321 Endometrial Neoplasms 319 Hematologic Neoplasms 314 Recurrence 299 Disease 275

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Chemotherapy × Clear all

NCT03701607 2018-10-10

Effect of Chemotherapy on PD-L1 in NSCLC

Shanghai Changzheng Hospital

Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡